ArticleOncoTargets and therapy2019

Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.